<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Head Neck</journal-id><journal-id journal-id-type="iso-abbrev">Head Neck</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1097-0347</journal-id><journal-id journal-id-type="publisher-id">HED</journal-id><journal-title-group><journal-title>Head &#x00026; Neck</journal-title></journal-title-group><issn pub-type="ppub">1043-3074</issn><issn pub-type="epub">1097-0347</issn><publisher><publisher-name>John Wiley &#x00026; Sons, Inc.</publisher-name><publisher-loc>Hoboken, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7267296</article-id><article-id pub-id-type="doi">10.1002/hed.26200</article-id><article-id pub-id-type="publisher-id">HED26200</article-id><article-categories><subj-group subj-group-type="overline"><subject>Special Issue</subject></subj-group><subj-group subj-group-type="heading"><subject>Otolaryngology&#x02010;head and Neck Surgery</subject></subj-group></article-categories><title-group><article-title>Topical preparations to reduce <styled-content style="fixed-case" toggle="no">SARS&#x02010;CoV</styled-content>&#x02010;2 aerosolization in head and neck mucosal surgery</article-title><alt-title alt-title-type="left-running-head">Parhar et al.</alt-title></title-group><contrib-group><contrib id="hed26200-cr-0001" contrib-type="author" corresp="yes"><name><surname>Parhar</surname><given-names>Harman S.</given-names></name><degrees>MD, MPH</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7975-8452</contrib-id><xref ref-type="aff" rid="hed26200-aff-0001">
<sup>1</sup>
</xref><address><email>harman.parhar@pennmedicine.upenn.edu</email></address></contrib><contrib id="hed26200-cr-0002" contrib-type="author"><name><surname>Tasche</surname><given-names>Kendall</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="hed26200-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="hed26200-cr-0003" contrib-type="author"><name><surname>Brody</surname><given-names>Robert M.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="hed26200-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="hed26200-cr-0004" contrib-type="author"><name><surname>Weinstein</surname><given-names>Gregory S.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="hed26200-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="hed26200-cr-0005" contrib-type="author"><name><surname>O'Malley</surname><given-names>Bert W.</given-names><suffix>Jr</suffix></name><degrees>MD</degrees><xref ref-type="aff" rid="hed26200-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="hed26200-cr-0006" contrib-type="author"><name><surname>Shanti</surname><given-names>Rabie M.</given-names></name><degrees>DMD, MD</degrees><xref ref-type="aff" rid="hed26200-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="hed26200-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="hed26200-cr-0007" contrib-type="author"><name><surname>Newman</surname><given-names>Jason G.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="hed26200-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="hed26200-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Otorhinolaryngology&#x02014;Head and Neck Surgery</named-content>
<institution>University of Pennsylvania</institution>
<city>Philadelphia</city>
<named-content content-type="country-part">Pennsylvania</named-content>
<country country="US">USA</country>
</aff><aff id="hed26200-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Oral and Maxillofacial Surgery</named-content>
<institution>University of Pennsylvania</institution>
<city>Philadelphia</city>
<named-content content-type="country-part">Pennsylvania</named-content>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Harman S. Parhar, MD, MPH, Department of Otorhinolaryngology&#x02014;Head and Neck Surgery, University of Pennsylvania, 3400 Spruce Street, 5 Ravdin, Philadelphia, PA 19104.<break/>
Email: <email>harman.parhar@pennmedicine.upenn.edu</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>4</month><year>2020</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2020</year></pub-date><volume>42</volume><issue>6</issue><issue-id pub-id-type="doi">10.1002/hed.v42.6</issue-id><fpage>1268</fpage><lpage>1272</lpage><history><date date-type="received"><day>07</day><month>4</month><year>2020</year></date><date date-type="accepted"><day>09</day><month>4</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 Wiley Periodicals, Inc. <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2020 Wiley Periodicals, Inc.</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:HED-42-1268.pdf"/><abstract><title>Abstract</title><sec id="hed26200-sec-0001"><title>Aim</title><p>The COVID&#x02010;19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS&#x02010;CoV&#x02010;2) has put health care workers at risk when exposed to aerosolized viral particles during upper airway mucosal surgery. The objective of this review was to discuss topical preparations that could be utilized preoperatively to help to decrease viral load and potentially reduce the risks of viral transmission.</p></sec><sec id="hed26200-sec-0002"><title>Methods</title><p>A PubMed/MEDLINE database review of articles was performed querying topical preparations with virucidal activity against coronaviruses.</p></sec><sec id="hed26200-sec-0003"><title>Results</title><p>Povidone&#x02010;iodine (PVP&#x02010;I) solutions ranging from 0.23% to 7% have been found to demonstrate highly effective virucidal activity against a broad range of viruses including several coronaviruses responsible for recent epidemics including SARS&#x02010;CoV&#x02010;1 and MERS&#x02010;CoV.</p></sec><sec id="hed26200-sec-0004"><title>Conclusions</title><p>While specific evidence regarding SARS&#x02010;CoV&#x02010;2 is lacking, PVP&#x02010;I&#x02010;based preparations have been successfully demonstrated to reduce viral loads of coronaviruses. They are relatively safe to use in the upper airway and may reduce risk of SARS&#x02010;CoV&#x02010;2 aerosolization during upper airway mucosal surgery.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="hed26200-kwd-0001">coronavirus</kwd><kwd id="hed26200-kwd-0002">COVID&#x02010;19</kwd><kwd id="hed26200-kwd-0003">head and neck cancer</kwd><kwd id="hed26200-kwd-0004">safety</kwd><kwd id="hed26200-kwd-0005">SARS&#x02010;CoV&#x02010;2</kwd></kwd-group><counts><fig-count count="0"/><table-count count="0"/><page-count count="5"/><word-count count="3364"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>June 2020</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.3 mode:remove_FC converted:03.06.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="hed26200-cit-9001">
<string-name>
<surname>Parhar</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Tasche</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Brody</surname>
<given-names>RM</given-names>
</string-name>, et al. <article-title>Topical preparations to reduce SARS&#x02010;CoV&#x02010;2 aerosolization in head and neck mucosal surgery</article-title>. <source xml:lang="en">Head &#x00026; Neck</source>. <year>2020</year>;<volume>42</volume>:<fpage>1268</fpage>&#x02013;<lpage>1272</lpage>. <pub-id pub-id-type="doi">10.1002/hed.26200</pub-id>
<pub-id pub-id-type="pmid">32333619</pub-id></mixed-citation>
</p></notes></front><body id="hed26200-body-0001"><sec id="hed26200-sec-0005"><label>1</label><title>INTRODUCTION</title><p>As the COVID&#x02010;19 pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS&#x02010;CoV&#x02010;2) continues to escalate globally, we are faced with developing methods to provide care to our patients while also keeping them our coworkers and ourselves safe. Health care workers are at increased risk of exposure to the virus, and there is mounting evidence that otolaryngologists are among the highest at risk. This is likely due to a high viral load of SARS&#x02010;CoV&#x02010;2 in the upper aerodigestive tract and because of the direct contact that practitioners have with the mucosa during both diagnostic and therapeutic procedures.<xref rid="hed26200-bib-0001" ref-type="ref">1</xref>, <xref rid="hed26200-bib-0002" ref-type="ref">2</xref>, <xref rid="hed26200-bib-0003" ref-type="ref">3</xref> Once the respiratory mucosa is manipulated, viral particles have the ability to become aerosolized, can become airborne for 3 or more hours, and may spread to contaminate multiple surfaces in the surrounding area.<xref rid="hed26200-bib-0004" ref-type="ref">4</xref>, <xref rid="hed26200-bib-0005" ref-type="ref">5</xref>, <xref rid="hed26200-bib-0006" ref-type="ref">6</xref> Of particular concern is that even asymptomatic patients may be responsible for viral aerosolization, given its long incubation period (5&#x02010;7&#x02009;days) and that these asymptomatic patients may unknowingly place our surgical teams at risk.<xref rid="hed26200-bib-0001" ref-type="ref">1</xref>, <xref rid="hed26200-bib-0007" ref-type="ref">7</xref>, <xref rid="hed26200-bib-0008" ref-type="ref">8</xref>, <xref rid="hed26200-bib-0009" ref-type="ref">9</xref>
</p><p>We do, however, still have an obligation to perform urgent and emergent cases for life&#x02010;threatening situations or diseases, such as cancer, where failure to act will lead to high morbidity. Indeed, it is known that patients with cancer are susceptible to infection. Early data from China have shown that among patients with COVID&#x02010;19, there is an approximately 3&#x02010;fold higher proportion of patients with cancer than the incidence of cancer in the general population.<xref rid="hed26200-bib-0010" ref-type="ref">
<sup>10</sup>
</xref> Open, endoscopic and robotic oncologic surgery of the upper airway may expose providers to high levels of viral particles in the respiratory mucosa and saliva.<xref rid="hed26200-bib-0002" ref-type="ref">2</xref>, <xref rid="hed26200-bib-0011" ref-type="ref">11</xref> Several institutions have generated head&#x02010; and neck&#x02010;specific algorithms to help risk stratify patients and procedures advocating strongly for preoperative SARS&#x02010;CoV&#x02010;2 testing and appropriate utilization of personal protective equipment in patients undergoing head and neck mucosal surgery.<xref rid="hed26200-bib-0012" ref-type="ref">12</xref>, <xref rid="hed26200-bib-0013" ref-type="ref">13</xref> There has been very little published, however, regarding whether there exist any topical agents that could be utilized preoperatively to potentially lower the viral load in the upper aerodigestive tract thereby mitigating any risk of viral aerosolization in persons undergoing head and neck mucosal surgery. In this review, we aimed to review the literature discussing topical agents that are safe to use as oral rinses and that may have virucidal activity against SARS&#x02010;CoV&#x02010;2.</p></sec><sec id="hed26200-sec-0006"><label>2</label><title>METHODS</title><p>We conducted a search of the PubMed/MEDLINE databases for articles relevant to topical agents with virucidal activity against coronaviruses. Search terms included are alcohol, peridex, iodine, chlorhexidine, topical, mouthwash, virus, coronavirus, and COVID&#x02010;19. To focus the search, we concentrated on articles that focused either on in vitro studies or studies examining their utilization on mucosal surfaces. We supplemented the searches by reviewing references from each relevant manuscript. The selection of data was determined subjectively to be synthesized into this review. Institutional review board approval was not required for this study.</p></sec><sec id="hed26200-sec-0007"><label>3</label><title>DISCUSSION</title><sec id="hed26200-sec-0008"><label>3.1</label><title>Povidone&#x02010;iodine</title><p>Povidone&#x02010;iodine (PVP&#x02010;I) is a widely used iodine complex carried in a polyvinylpyrrolidone carrier that was developed in the 1950s and is available as a surgical skin prep agent and as a mouthwash.<xref rid="hed26200-bib-0014" ref-type="ref">
<sup>14</sup>
</xref> It has demonstrated both antibacterial and antiviral activities in past studies.<xref rid="hed26200-bib-0014" ref-type="ref">
<sup>14</sup>
</xref> While studies on virucidal activity of PVP&#x02010;I have not yet been performed specifically on SARS&#x02010;CoV&#x02010;2, there have been numerous in vitro studies demonstrating its effectiveness against multiple viruses including related coronaviruses. A 1997 study compared PVP&#x02010;I to other antiseptics in inactivating a broad range of both enveloped and nonenveloped viruses (adenovirus, mumps, rotavirus, poliovirus, Coxsackievirus, rhinovirus, herpes simplex virus, rubella, measles, influenza, and HIV) and demonstrated PVP&#x02010;I to have the broadest spectrum of antiviral activity among agents tested.<xref rid="hed26200-bib-0015" ref-type="ref">
<sup>15</sup>
</xref> Kariwa et al tested several different commercially available PVP&#x02010;I formulations against SARS&#x02010;CoV&#x02010;1 viral samples (responsible for the SARS epidemic) and found that the viral infectivity was reduced to below detectable levels within 2&#x02009;minutes of application.<xref rid="hed26200-bib-0016" ref-type="ref">
<sup>16</sup>
</xref> In an industry&#x02010;sponsored study, Eggers et al carried out in vitro tests of PVP&#x02010;I solutions (1%&#x02010;7.5%) against Middle East respiratory syndrome coronavirus (MERS&#x02010;CoV; responsible for the MERS epidemic) and found that the viral titer reduction of &#x0003e;99.99% within 15&#x02009;seconds of application.<xref rid="hed26200-bib-0017" ref-type="ref">
<sup>17</sup>
</xref> A subsequent study examined a diluted PVP&#x02010;I (0.23%) formulation against SARS&#x02010;CoV&#x02010;1, MERS&#x02010;CoV, and influenza A (H1N1) applied for 15&#x02009;seconds and again found a &#x0003e;99.99% reduction of viral titers.<xref rid="hed26200-bib-0018" ref-type="ref">
<sup>18</sup>
</xref> Despite ample in vitro studies, there are few clinical studies of PVP&#x02010;I specifically against viruses. Still, in a small prospective Japanese study of school&#x02010;aged children, it was found that cohorts who were encouraged to used PVP&#x02010;I gargle had significantly lower rates of absences from school due to the common cold and influenza.<xref rid="hed26200-bib-0019" ref-type="ref">
<sup>19</sup>
</xref>
</p><p>From a safety perspective, it has been tolerated for use in the upper airway as has been demonstrated in numerous human studies. In the oral cavity and oropharynx it has been used safely at a range of doses from 1% to 10% for oropharyngeal infection prophylaxis, mucositis, and prevention of ventilator&#x02010;associated pneumonia.<xref rid="hed26200-bib-0020" ref-type="ref">20</xref>, <xref rid="hed26200-bib-0021" ref-type="ref">21</xref>, <xref rid="hed26200-bib-0022" ref-type="ref">22</xref>, <xref rid="hed26200-bib-0023" ref-type="ref">23</xref>, <xref rid="hed26200-bib-0024" ref-type="ref">24</xref> Commercial over&#x02010;the&#x02010;counter oral mouthrinse formulations are typically of 1% PVP&#x02010;I. Though there is some degree of mucosal absorption, even long&#x02010;term oral utilization has not been shown to cause thyroid dysfunction.<xref rid="hed26200-bib-0025" ref-type="ref">
<sup>25</sup>
</xref> It has also been utilized in the sinonasal mucosa at lower concentrations (0.08%) in the treatment of recalcitrant chronic rhinosinusitis without evidence of thyroid dysfunction, olfactory dysfunction, or mucociliary clearance changes.<xref rid="hed26200-bib-0026" ref-type="ref">
<sup>26</sup>
</xref> Other studies have examined the effect of PVP&#x02010;I in varying concentrations from 0.5% to 5% on the sinonasal mucosa without detrimental effect to the nasal epithelium; however, one recent in vitro study found that iodine preparations of 5% to 10% demonstrated ciliotoxicity.<xref rid="hed26200-bib-0027" ref-type="ref">27</xref>, <xref rid="hed26200-bib-0028" ref-type="ref">28</xref>, <xref rid="hed26200-bib-0029" ref-type="ref">29</xref>, <xref rid="hed26200-bib-0030" ref-type="ref">30</xref> Fortunately, PVP&#x02010;I also exhibits the least ototoxicity of topical preparation solutions and is safe to use as an ophthalmic preparation agent (1%&#x02010;5%), which is relevant to head and neck procedure that involves or exposes the skull base otologic or orbital apparatuses.<xref rid="hed26200-bib-0031" ref-type="ref">31</xref>, <xref rid="hed26200-bib-0032" ref-type="ref">32</xref> Unlike alcohol&#x02010;based preparations, it is not flammable which is relevant when using electrocautery in the airway.<xref rid="hed26200-bib-0033" ref-type="ref">
<sup>33</sup>
</xref>
</p></sec><sec id="hed26200-sec-0009"><label>3.2</label><title>Chlorhexidine</title><p>Chlorhexidine is a disinfectant and antiseptic that has been in medical use since the 1950s. Oral rinse preparations are commonly used in dentistry to reduce plaque build&#x02010;up and treat gingivitis, and studies show that it can reduce bacterial counts in saliva after as little as 30&#x02009;seconds of exposure.<xref rid="hed26200-bib-0034" ref-type="ref">
<sup>34</sup>
</xref> There is more limited evidence showing its virucidal effects. in vitro studies in the 1970s first demonstrated the activity of chlorhexidine gluconate against herpes virus strains though not poliovirus or adenovirus.<xref rid="hed26200-bib-0035" ref-type="ref">
<sup>35</sup>
</xref> Later studies showed that chlorhexidine tends to have virucidal activity against enveloped viruses, though does not show the same effect against nonenveloped viruses. Bernstein et al showed virucidal activity of chlorhexidine gluconate against the enveloped viruses herpes virus 1, cytomegalovirus, influenza A, parainfluenza, and hepatitis B after 5&#x02009;minutes of exposure in vitro, with no activity against poliovirus.<xref rid="hed26200-bib-0036" ref-type="ref">
<sup>36</sup>
</xref> Baqui demonstrated this effect against HIV&#x02010;1 in vitro as well with two preparations of chlorhexidine as well as Listerine mouthwashes.<xref rid="hed26200-bib-0037" ref-type="ref">
<sup>37</sup>
</xref> There are few studies examining chlorhexidine and coronaviruses, and those that do exist examine the effects of chlorhexidine on sterilization of inert surfaces rather than living tissue. These studies do, however, show sensitivity of coronavirus to chlorhexidine though only when used in combination with other compounds such as ethanol or cetrimide.<xref rid="hed26200-bib-0038" ref-type="ref">
<sup>38</sup>
</xref> In isolation, chlorhexidine has been found to be less effective against coronaviruses than PVP&#x02010;I in both in vitro studies and studies of disinfection of inanimate surfaces.<xref rid="hed26200-bib-0015" ref-type="ref">15</xref>, <xref rid="hed26200-bib-0039" ref-type="ref">39</xref> Overall, there are limited data demonstrating the activity of chlorhexidine against coronaviruses and it is also associated with high levels of ototoxicity and can be flammable when utilized in commercial preparations that commonly include alcohol.<xref rid="hed26200-bib-0031" ref-type="ref">31</xref>, <xref rid="hed26200-bib-0033" ref-type="ref">33</xref>
</p></sec><sec id="hed26200-sec-0010"><label>3.3</label><title>Recommendation</title><p>On the basis of this review, the authors believe that the topical application of PVP&#x02010;I is safe and may help to reduce the viral load, and the potential aerosolization, of SARS&#x02010;CoV&#x02010;2. Until confirmatory studies are conducted, our institutional consensus is to dilute commonly available PVP&#x02010;I (typically 7.5%) 1:3 with saline to achieve a less than 2% concentration and bulb syringe the solution into the oral/nasal cavity, after intubation, but immediately prior to head and neck procedures that require instrumentation of the upper airway mucosa during the COVID&#x02010;19 pandemic. We suggest leaving the solution in for approximately 1&#x02009;minute before irrigating with saline and suctioning it out to reduce residual absorption and limit tissue staining &#x02013; though the optimal concentration and application time, if any, are currently unknown. This procedure is applied to both COVID&#x02010;19&#x02010;positive adult patients and to patients with unknown status unless they have a contraindication to topical iodine (allergy/anaphylaxis, labile thyroid disease, contact dermatitis, pregnancy/nursing, active radioiodine therapy). This concentration is over 8 times the lowest PVP&#x02010;I concentration found to be effective in vitro to eliminate related coronaviruses but still likely a safe concentration for one&#x02010;time use based upon past studies described. Due to a paucity of supporting literature, no recommendation can be made for the use of chlorhexidine&#x02010;based rinses.</p></sec></sec><sec id="hed26200-sec-0011"><label>4</label><title>CONCLUSIONS</title><p>Though no topical therapies have been studied to specifically reduce the viral load and potential aerosolization of SARS&#x02010;CoV&#x02010;2 during upper airway mucosal surgery, PVP&#x02010;I solutions have demonstrated effective virucidal activity against related coronaviruses in numerous studies. They are relatively safe to use in the upper airway, require very brief application times, and may potentially reduce the risk of SARS&#x02010;CoV&#x02010;2 aerosolization and transmission during upper airway mucosal surgery.</p></sec><sec sec-type="COI-statement" id="hed26200-sec-0012"><title>CONFLICT OF INTEREST</title><p>This work has never been published or presented anywhere. The authors declare no potential conflict of interest.</p></sec></body><back><ref-list id="hed26200-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="hed26200-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="hed26200-cit-0001">
<string-name>
<surname>Chang</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Rebaza</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sharma</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Dela Cruz</surname>
<given-names>CS</given-names>
</string-name>. <article-title>Protecting health&#x02010;care workers from subclinical coronavirus infection</article-title>. <source xml:lang="en">Lancet Respir Med</source>. <year>2020</year>;<volume>8</volume>(<issue>3</issue>):<elocation-id>e13</elocation-id>
<pub-id pub-id-type="doi">10.1016/S2213-2600(20)30066-7</pub-id>.<pub-id pub-id-type="pmid">32061333</pub-id></mixed-citation></ref><ref id="hed26200-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="hed26200-cit-0002">
<string-name>
<surname>Zou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ruan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>SARS&#x02010;CoV&#x02010;2 viral load in upper respiratory specimens of infected patients</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2020</year>;<volume>382</volume>(<issue>12</issue>):<fpage>1177</fpage>&#x02010;<lpage>1179</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc2001737</pub-id>.<pub-id pub-id-type="pmid">32074444</pub-id></mixed-citation></ref><ref id="hed26200-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="hed26200-cit-0003">
<string-name>
<surname>Lu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Integrated infection control strategy to minimize nosocomial infection of coronavirus disease 2019 among ENT healthcare workers</article-title>. <source xml:lang="en">J Hosp Infect</source>. <year>2020</year>;<volume>104</volume>:<fpage>454</fpage>&#x02010;<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhin.2020.02.018</pub-id>.<pub-id pub-id-type="pmid">32114056</pub-id></mixed-citation></ref><ref id="hed26200-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="hed26200-cit-0004">
<string-name>
<surname>van Doremalen</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bushmaker</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>DH</given-names>
</string-name>, et al. <article-title>Aerosol and surface stability of SARS&#x02010;CoV&#x02010;2 as compared with SARS&#x02010;CoV&#x02010;1</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2020</year>;<volume>382</volume>:<fpage>1564</fpage>&#x02010;<lpage>1567</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc2004973</pub-id>.<pub-id pub-id-type="pmid">32182409</pub-id></mixed-citation></ref><ref id="hed26200-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="hed26200-cit-0005">
<string-name>
<surname>Ong</surname>
<given-names>SWX</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>YK</given-names>
</string-name>, <string-name>
<surname>Chia</surname>
<given-names>PY</given-names>
</string-name>, et al. <article-title>Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS&#x02010;CoV&#x02010;2) from a symptomatic patient</article-title>. <source xml:lang="en">JAMA</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1001/jama.2020.3227</pub-id>.</mixed-citation></ref><ref id="hed26200-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="hed26200-cit-0006">
<string-name>
<surname>Workman</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Welling</surname>
<given-names>DB</given-names>
</string-name>, <string-name>
<surname>Carter</surname>
<given-names>BS</given-names>
</string-name>, et al. <article-title>Endonasal instrumentation and aerosolization risk in the era of COVID&#x02010;19: simulation, literature review, and proposed mitigation strategies</article-title>. <source xml:lang="en">Int Forum Allergy Rhinol</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1002/alr.22577</pub-id>.</mixed-citation></ref><ref id="hed26200-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="hed26200-cit-0007">
<string-name>
<surname>Chan</surname>
<given-names>JF&#x02010;W</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kok</surname>
<given-names>K&#x02010;H</given-names>
</string-name>, et al. <article-title>A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person&#x02010;to&#x02010;person transmission: a study of a family cluster</article-title>. <source xml:lang="en">Lancet</source>. <year>2020</year>;<volume>395</volume>(<issue>10223</issue>):<fpage>514</fpage>&#x02010;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30154-9</pub-id>.<pub-id pub-id-type="pmid">31986261</pub-id></mixed-citation></ref><ref id="hed26200-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="hed26200-cit-0008">
<string-name>
<surname>Lai</surname>
<given-names>C&#x02010;C</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>C&#x02010;Y</given-names>
</string-name>, et al. <article-title>Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS&#x02010;CoV&#x02010;2): facts and myths</article-title>. <source xml:lang="en">J Microbiol Immunol Infect</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1016/j.jmii.2020.02.012</pub-id>.</mixed-citation></ref><ref id="hed26200-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="hed26200-cit-0009">
<string-name>
<surname>Rothe</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Schunk</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sothmann</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Transmission of 2019&#x02010;nCoV infection from an asymptomatic contact in Germany</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2020</year>;<volume>382</volume>(<issue>10</issue>):<fpage>970</fpage>&#x02010;<lpage>971</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc2001468</pub-id>.<pub-id pub-id-type="pmid">32003551</pub-id></mixed-citation></ref><ref id="hed26200-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="hed26200-cit-0010">
<string-name>
<surname>Liang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Guan</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Cancer patients in SARS&#x02010;CoV&#x02010;2 infection: a nationwide analysis in China</article-title>. <source xml:lang="en">Lancet Oncol</source>. <year>2020</year>;<volume>21</volume>(<issue>3</issue>):<fpage>335</fpage>&#x02010;<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1016/S1470-2045(20)30096-6</pub-id>.<pub-id pub-id-type="pmid">32066541</pub-id></mixed-citation></ref><ref id="hed26200-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="hed26200-cit-0011">
<string-name>
<surname>To</surname>
<given-names>KK&#x02010;W</given-names>
</string-name>, <string-name>
<surname>Tsang</surname>
<given-names>OT&#x02010;Y</given-names>
</string-name>, <string-name>
<surname>Chik&#x02010;Yan Yip</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Consistent detection of 2019 novel coronavirus in saliva</article-title>. <source xml:lang="en">Clin Infect Dis</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1093/cid/ciaa149</pub-id>.</mixed-citation></ref><ref id="hed26200-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="hed26200-cit-0012">
<string-name>
<surname>Givi</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Schiff</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Chinn</surname>
<given-names>SB</given-names>
</string-name>, et al. <article-title>Safety recommendations for evaluation and surgery of the head and neck during the COVID&#x02010;19 pandemic</article-title>. <source xml:lang="en">JAMA Otolaryngol Head Neck Surg</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1001/jamaoto.2020.0780</pub-id>.</mixed-citation></ref><ref id="hed26200-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="hed26200-cit-0013">
<string-name>
<surname>Vukkadala</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Qian</surname>
<given-names>ZJ</given-names>
</string-name>, <string-name>
<surname>Holsinger</surname>
<given-names>FC</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>ZM</given-names>
</string-name>, <string-name>
<surname>Rosenthal</surname>
<given-names>E</given-names>
</string-name>. <article-title>COVID&#x02010;19 and the otolaryngologist&#x02014;preliminary evidence&#x02010;based review</article-title>. <source xml:lang="en">Laryngoscope</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1002/lary.28672</pub-id>.</mixed-citation></ref><ref id="hed26200-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="hed26200-cit-0014">
<string-name>
<surname>Berkelman</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Holland</surname>
<given-names>BW</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>RL</given-names>
</string-name>. <article-title>Increased bactericidal activity of dilute preparations of povidone&#x02010;iodine solutions</article-title>. <source xml:lang="en">J Clin Microbiol</source>. <year>1982</year>;<volume>15</volume>(<issue>4</issue>):<fpage>635</fpage>&#x02010;<lpage>639</lpage>.<pub-id pub-id-type="pmid">7040461</pub-id></mixed-citation></ref><ref id="hed26200-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="hed26200-cit-0015">
<string-name>
<surname>Kawana</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kitamura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nakagomi</surname>
<given-names>O</given-names>
</string-name>, et al. <article-title>Inactivation of human viruses by povidone&#x02010;iodine in comparison with other antiseptics</article-title>. <source xml:lang="en">Dermatology (Basel)</source>. <year>1997</year>;<volume>195</volume>(<issue>suppl 2</issue>):<fpage>29</fpage>&#x02010;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1159/000246027</pub-id>.</mixed-citation></ref><ref id="hed26200-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="hed26200-cit-0016">
<string-name>
<surname>Kariwa</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Fujii</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Takashima</surname>
<given-names>I</given-names>
</string-name>. <article-title>Inactivation of SARS coronavirus by means of povidone&#x02010;iodine, physical conditions and chemical reagents</article-title>. <source xml:lang="en">Dermatology (Basel)</source>. <year>2006</year>;<volume>212</volume>(<issue>suppl 1</issue>):<fpage>119</fpage>&#x02010;<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1159/000089211</pub-id>.<pub-id pub-id-type="pmid">16490989</pub-id></mixed-citation></ref><ref id="hed26200-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="hed26200-cit-0017">
<string-name>
<surname>Eggers</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Eickmann</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zorn</surname>
<given-names>J</given-names>
</string-name>. <article-title>Rapid and effective virucidal activity of povidone&#x02010;iodine products against Middle East respiratory syndrome coronavirus (MERS&#x02010;CoV) and modified vaccinia virus Ankara (MVA)</article-title>. <source xml:lang="en">Infect Dis Ther</source>. <year>2015</year>;<volume>4</volume>(<issue>4</issue>):<fpage>491</fpage>&#x02010;<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1007/s40121-015-0091-9</pub-id>.<pub-id pub-id-type="pmid">26416214</pub-id></mixed-citation></ref><ref id="hed26200-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="hed26200-cit-0018">
<string-name>
<surname>Eggers</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Koburger&#x02010;Janssen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Eickmann</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zorn</surname>
<given-names>J</given-names>
</string-name>. <article-title>In vitro bactericidal and virucidal efficacy of povidone&#x02010;iodine gargle/mouthwash against respiratory and oral tract pathogens</article-title>. <source xml:lang="en">Infect Dis Ther</source>. <year>2018</year>;<volume>7</volume>(<issue>2</issue>):<fpage>249</fpage>&#x02010;<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1007/s40121-018-0200-7</pub-id>.<pub-id pub-id-type="pmid">29633177</pub-id></mixed-citation></ref><ref id="hed26200-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="hed26200-cit-0019">
<string-name>
<surname>Shiraishi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nakagawa</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Evaluation of the bactericidal activity of povidone&#x02010;iodine and commercially available gargle preparations</article-title>. <source xml:lang="en">Dermatol (Basel)</source>. <year>2002</year>;<volume>204</volume>(<issue>suppl 1</issue>):<fpage>37</fpage>&#x02010;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1159/000057723</pub-id>.</mixed-citation></ref><ref id="hed26200-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="hed26200-cit-0020">
<string-name>
<surname>Nagatake</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ahmed</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Oishi</surname>
<given-names>K</given-names>
</string-name>. <article-title>Prevention of respiratory infections by povidone&#x02010;iodine gargle</article-title>. <source xml:lang="en">Dermatol (Basel)</source>. <year>2002</year>;<volume>204</volume>(<issue>suppl 1</issue>):<fpage>32</fpage>&#x02010;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1159/000057722</pub-id>.</mixed-citation></ref><ref id="hed26200-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="hed26200-cit-0021">
<string-name>
<surname>Tsuda</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Soutome</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hayashida</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Funahara</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yanamoto</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Umeda</surname>
<given-names>M</given-names>
</string-name>. <article-title>Topical povidone iodine inhibits bacterial growth in the oral cavity of patients on mechanical ventilation: a randomized controlled study</article-title>. <source xml:lang="en">BMC Oral Health</source>. <year>2020</year>;<volume>20</volume>(<issue>1</issue>):<fpage>62</fpage>
<pub-id pub-id-type="doi">10.1186/s12903-020-1043-7</pub-id>.<pub-id pub-id-type="pmid">32093667</pub-id></mixed-citation></ref><ref id="hed26200-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="hed26200-cit-0022">
<string-name>
<surname>Okuda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kaneko</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ichinohe</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ishihara</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Okuda</surname>
<given-names>K</given-names>
</string-name>. <article-title>Reduction of potential respiratory pathogens by oral hygienic treatment in patients undergoing endotracheal anesthesia</article-title>. <source xml:lang="en">J Anesth</source>. <year>2003</year>;<volume>17</volume>(<issue>2</issue>):<fpage>84</fpage>&#x02010;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1007/s005400300022</pub-id>.<pub-id pub-id-type="pmid">12903918</pub-id></mixed-citation></ref><ref id="hed26200-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="hed26200-cit-0023">
<string-name>
<surname>Seguin</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Tanguy</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Laviolle</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Tirel</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Mall&#x000e9;dant</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Effect of oropharyngeal decontamination by povidone&#x02010;iodine on ventilator&#x02010;associated pneumonia in patients with head trauma</article-title>. <source xml:lang="en">Crit Care Med</source>. <year>2006</year>;<volume>34</volume>(<issue>5</issue>):<fpage>1514</fpage>&#x02010;<lpage>1519</lpage>. <pub-id pub-id-type="doi">10.1097/01.CCM.0000214516.73076.82</pub-id>.<pub-id pub-id-type="pmid">16540962</pub-id></mixed-citation></ref><ref id="hed26200-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="hed26200-cit-0024">
<string-name>
<surname>Adamietz</surname>
<given-names>IA</given-names>
</string-name>, <string-name>
<surname>Rahn</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>B&#x000f6;ttcher</surname>
<given-names>HD</given-names>
</string-name>, <string-name>
<surname>Sch&#x000e4;fer</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Reimer</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Fleischer</surname>
<given-names>W</given-names>
</string-name>. <article-title>Prophylaxis with povidone&#x02010;iodine against induction of oral mucositis by radiochemotherapy</article-title>. <source xml:lang="en">Support Care Cancer</source>. <year>1998</year>;<volume>6</volume>(<issue>4</issue>):<fpage>373</fpage>&#x02010;<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1007/s005200050179</pub-id>.<pub-id pub-id-type="pmid">9695205</pub-id></mixed-citation></ref><ref id="hed26200-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="hed26200-cit-0025">
<string-name>
<surname>Ader</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Paul</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Reinhardt</surname>
<given-names>W</given-names>
</string-name>, et al. <article-title>Effect of mouth rinsing with two polyvinylpyrrolidone&#x02010;iodine mixtures on iodine absorption and thyroid function</article-title>. <source xml:lang="en">J Clin Endocrinol Metab</source>. <year>1988</year>;<volume>66</volume>(<issue>3</issue>):<fpage>632</fpage>&#x02010;<lpage>635</lpage>. <pub-id pub-id-type="doi">10.1210/jcem-66-3-632</pub-id>.<pub-id pub-id-type="pmid">3350910</pub-id></mixed-citation></ref><ref id="hed26200-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="hed26200-cit-0026">
<string-name>
<surname>Panchmatia</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Payandeh</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Al&#x02010;Salman</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>The efficacy of diluted topical povidone&#x02010;iodine rinses in the management of recalcitrant chronic rhinosinusitis: a prospective cohort study</article-title>. <source xml:lang="en">Eur Arch Otorhinolaryngol</source>. <year>2019</year>;<volume>276</volume>(<issue>12</issue>):<fpage>3373</fpage>&#x02010;<lpage>3381</lpage>. <pub-id pub-id-type="doi">10.1007/s00405-019-05628-w</pub-id>.<pub-id pub-id-type="pmid">31560120</pub-id></mixed-citation></ref><ref id="hed26200-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="hed26200-cit-0027">
<string-name>
<surname>Ramezanpour</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>JLP</given-names>
</string-name>, <string-name>
<surname>Psaltis</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Wormald</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Vreugde</surname>
<given-names>S</given-names>
</string-name>. <article-title>In vitro safety evaluation of a povidone&#x02010;iodine solution applied to human nasal epithelial cells</article-title>. <source xml:lang="en">Int Forum Allergy Rhinol</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1002/alr.22575</pub-id>.</mixed-citation></ref><ref id="hed26200-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="hed26200-cit-0028">
<string-name>
<surname>Kim</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Rimmer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Mrad</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ahmadzada</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Harvey</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Betadine has a ciliotoxic effect on ciliated human respiratory cells</article-title>. <source xml:lang="en">J Laryngol Otol</source>. <year>2015</year>;<volume>129</volume>(<issue>suppl 1</issue>):<fpage>S45</fpage>&#x02010;<lpage>S50</lpage>. <pub-id pub-id-type="doi">10.1017/S0022215114002746</pub-id>.<pub-id pub-id-type="pmid">25363372</pub-id></mixed-citation></ref><ref id="hed26200-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="hed26200-cit-0029">
<string-name>
<surname>Gluck</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Martin</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Bosse</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Reimer</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Mueller</surname>
<given-names>S</given-names>
</string-name>. <article-title>A clinical study on the tolerability of a liposomal povidone&#x02010;iodine nasal spray: implications for further development</article-title>. <source xml:lang="en">ORL J Otorhinolaryngol Relat Spec</source>. <year>2007</year>;<volume>69</volume>(<issue>2</issue>):<fpage>92</fpage>&#x02010;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1159/000097758</pub-id>.<pub-id pub-id-type="pmid">17148942</pub-id></mixed-citation></ref><ref id="hed26200-bib-0030"><label>30</label><mixed-citation publication-type="miscellaneous" id="hed26200-cit-0030">Safety &#x00026; Efficacy Information 3M Skin and Nasal Antiseptic; <year>2015</year>
<ext-link ext-link-type="uri" xlink:href="https://multimedia.3m.com/mws/media/716788O/3m-skin-and-nasal-antiseptic-safety-and-efficacy-brochure.pdf">https://multimedia.3m.com/mws/media/716788O/3m-skin-and-nasal-antiseptic-safety-and-efficacy-brochure.pdf</ext-link>. Accessed April 6, 2020.</mixed-citation></ref><ref id="hed26200-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="hed26200-cit-0031">
<string-name>
<surname>Singh</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Blakley</surname>
<given-names>B</given-names>
</string-name>. <article-title>Systematic review of ototoxic pre&#x02010;surgical antiseptic preparations&#x02014;what is the evidence?</article-title>
<source xml:lang="en">J Otolaryngol Head Neck Surg</source>. <year>2018</year>;<volume>47</volume>(<issue>1</issue>):<fpage>18</fpage>
<pub-id pub-id-type="doi">10.1186/s40463-018-0265-z</pub-id>.<pub-id pub-id-type="pmid">29490694</pub-id></mixed-citation></ref><ref id="hed26200-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="hed26200-cit-0032">
<string-name>
<surname>Ferguson</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Scott</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>McGavigan</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Comparison of 5% povidone&#x02010;iodine solution against 1% povidone&#x02010;iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study</article-title>. <source xml:lang="en">Br J Ophthalmol</source>. <year>2003</year>;<volume>87</volume>(<issue>2</issue>):<fpage>163</fpage>&#x02010;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1136/bjo.87.2.163</pub-id>.<pub-id pub-id-type="pmid">12543744</pub-id></mixed-citation></ref><ref id="hed26200-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="hed26200-cit-0033">
<string-name>
<surname>Hemani</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Lepor</surname>
<given-names>H</given-names>
</string-name>. <article-title>Skin preparation for the prevention of surgical site infection: which agent is best?</article-title>
<source xml:lang="en">Rev Urol</source>. <year>2009</year>;<volume>11</volume>(<issue>4</issue>):<fpage>190</fpage>&#x02010;<lpage>195</lpage>.<pub-id pub-id-type="pmid">20111631</pub-id></mixed-citation></ref><ref id="hed26200-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="hed26200-cit-0034">
<string-name>
<surname>Gultz</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kaim</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>DeLeo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Scherer</surname>
<given-names>W</given-names>
</string-name>. <article-title>An in vivo comparison of the antimicrobial activities of three mouthrinses</article-title>. <source xml:lang="en">J Clin Dent</source>. <year>1998</year>;<volume>9</volume>(<issue>2</issue>):<fpage>43</fpage>&#x02010;<lpage>45</lpage>.<pub-id pub-id-type="pmid">10518852</pub-id></mixed-citation></ref><ref id="hed26200-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="hed26200-cit-0035">
<string-name>
<surname>Bailey</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Longson</surname>
<given-names>M</given-names>
</string-name>. <article-title>Virucidal activity of chlorhexidine on strains of herpesvirus hominis, poliovirus, and adenovirus</article-title>. <source xml:lang="en">J Clin Pathol</source>. <year>1972</year>;<volume>25</volume>(<issue>1</issue>):<fpage>76</fpage>&#x02010;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1136/jcp.25.1.76</pub-id>.<pub-id pub-id-type="pmid">4335578</pub-id></mixed-citation></ref><ref id="hed26200-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="hed26200-cit-0036">
<string-name>
<surname>Bernstein</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Schiff</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Echler</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Prince</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Feller</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Briner</surname>
<given-names>W</given-names>
</string-name>. <article-title>In vitro virucidal effectiveness of a 0.12%&#x02010;chlorhexidine gluconate mouthrinse</article-title>. <source xml:lang="en">J Dent Res</source>. <year>1990</year>;<volume>69</volume>(<issue>3</issue>):<fpage>874</fpage>&#x02010;<lpage>876</lpage>. <pub-id pub-id-type="doi">10.1177/00220345900690030901</pub-id>.<pub-id pub-id-type="pmid">2109001</pub-id></mixed-citation></ref><ref id="hed26200-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="hed26200-cit-0037">
<string-name>
<surname>Baqui</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Kelley</surname>
<given-names>JI</given-names>
</string-name>, <string-name>
<surname>Jabra&#x02010;Rizk</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Depaola</surname>
<given-names>LG</given-names>
</string-name>, <string-name>
<surname>Falkler</surname>
<given-names>WA</given-names>
</string-name>, <string-name>
<surname>Meiller</surname>
<given-names>TF</given-names>
</string-name>. <article-title>In vitro effect of oral antiseptics on human immunodeficiency virus&#x02010;1 and herpes simplex virus type 1</article-title>. <source xml:lang="en">J Clin Periodontol</source>. <year>2001</year>;<volume>28</volume>(<issue>7</issue>):<fpage>610</fpage>&#x02010;<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1034/j.1600-051x.2001.028007610.x</pub-id>.<pub-id pub-id-type="pmid">11422581</pub-id></mixed-citation></ref><ref id="hed26200-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="hed26200-cit-0038">
<string-name>
<surname>Geller</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Varbanov</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Duval</surname>
<given-names>RE</given-names>
</string-name>. <article-title>Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies</article-title>. <source xml:lang="en">Viruses</source>. <year>2012</year>;<volume>4</volume>(<issue>11</issue>):<fpage>3044</fpage>&#x02010;<lpage>3068</lpage>. <pub-id pub-id-type="doi">10.3390/v4113044</pub-id>.<pub-id pub-id-type="pmid">23202515</pub-id></mixed-citation></ref><ref id="hed26200-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="hed26200-cit-0039">
<string-name>
<surname>Kampf</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Todt</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Pfaender</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Steinmann</surname>
<given-names>E</given-names>
</string-name>. <article-title>Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents</article-title>. <source xml:lang="en">J Hosp Infect</source>. <year>2020</year>;<volume>104</volume>(<issue>3</issue>):<fpage>246</fpage>&#x02010;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhin.2020.01.022</pub-id>.<pub-id pub-id-type="pmid">32035997</pub-id></mixed-citation></ref></ref-list></back></article>